24/7 Market News Snapshot 13 May, 2025 – Apyx Medical Corporation Common Stock (NASDAQ:APYX)

May 13, 2025

DENVER, Colo., 13 May, 2025 (www.247marketnews.com) – (NASDAQ:APYX) are discussed in this article.
Apyx Medical Corporation is currently experiencing a downturn, with shares trading at $1.090 in pre-market sessions, marking a 1.36% decrease from the prior closing price of $1.105. The trading volume has surged to 924.28K, suggesting increased investor engagement and potential concerns about the stock’s performance. This bearish trend may imply heightened selling pressure or negative sentiment surrounding the company, and the analysis of technical indicators, including moving averages, could yield additional insights into forthcoming price movements. Investors are advised to remain vigilant regarding these developments to better understand entry points and market trends.

In a noteworthy development, Apyx Medical has announced the receipt of 510(k) clearance from the U.S. Food and Drug Administration for its groundbreaking AYON Body Contouring System™. This system represents the first integrated platform designed specifically for aesthetic surgical applications, combining multiple advanced technologies that enhance the body contouring experience. It features innovative LIFT Technology, enabling real-time adjustments during procedures, thereby setting a new benchmark in surgical care.

Anticipating a significant rise in body contouring procedures, particularly among patients undergoing GLP-1 treatments for accelerated weight loss, Apyx Medical is preparing to showcase the AYON system to leading surgeons in the latter half of 2025. This initiative aims to equip surgeons with a versatile tool that streamlines fat removal, tissue contraction, and electrosurgical capabilities into one cohesive platform.

President and CEO Charlie Goodwin expressed enthusiasm for the AYON system, emphasizing its potential to transform the aesthetic surgical landscape by facilitating improved precision and outcomes. As Apyx Medical continues to innovate, the AYON Body Contouring System is set to play a pivotal role in meeting the growing demand for effective aesthetic solutions while reinforcing the company’s leadership in advanced energy technology.

Related news for (APYX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.